Sonoma Pharmaceuticals, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

7. Property and Equipment

7. Property and Equipment

12 Months Ended

Mar. 31, 2013

Property, Plant and Equipment [Abstract]

7. Property and Equipment

NOTE 7 — Property and Equipment

Property and equipment consists of the following (in thousands):

	March 31,
	2013			2012
Manufacturing, lab, and other equipment	$	2,731		$	2,666
Office equipment		356			334
Furniture and fixtures		78			55
Leasehold improvements		282			269
		3,447			3,324
Less: accumulated depreciation and amortization		(2,647	)		(2,518	)
	$	800		$	806

Depreciation and amortization expense amounted to $268,000 and $326,000 for the years ended March 31, 2013 and 2012, respectively.

During the year ended March 31, 2013, the Company incurred losses on the disposal of property and equipment in the amount of $2,000. This amount was recorded within operating expenses in the accompanying consolidated statements of comprehensive loss.

- Definition

The entire disclosure for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, accounting policies and methodology, roll forwards, depreciation, depletion and amortization expense, including composite depreciation, accumulated depreciation, depletion and amortization expense, useful lives and method used, income statement disclosures, assets held for sale and public utility disclosures.

+ References + Details